# The Impact of Body Surface Area on Morpho-Functional and Cardiometabolic Parameters in a Large Cohort of Olympic Athletes: Distinct Bodies, Distinct Physiology

**Authors:** Giuseppe Di Gioia, Maria Rosaria Squeo, Armando Ferrera, Lucrezia Macori, Margherita Rigillo, Raffaella Spada, Antonio Pelliccia

PMC · DOI: 10.3390/jfmk10040405 · Journal of Functional Morphology and Kinesiology · 2025-10-18

## TL;DR

This study shows that body surface area significantly affects heart and metabolic traits in Olympic athletes, with larger athletes showing different physiological patterns.

## Contribution

The study introduces a detailed analysis of how body surface area extremes influence cardiovascular and metabolic profiles in elite athletes.

## Key findings

- Male athletes with higher BSA had higher systolic blood pressure and dyslipidemia compared to those with lower BSA.
- Larger athletes showed greater left ventricular dimensions but lower functional performance, as measured by VO2 max/kg.
- Female athletes showed similar morpho-functional trends, but lipid profiles did not differ significantly among BSA groups.

## Abstract

Background: Body surface area is a key determinant of cardiac morphology and function, but it is often underestimated in the interpretation of athlete’s cardiac phenotypes. Aims: This study aimed to assess the role of anthropometric characteristics and whether particularly high vs. low body surface area (BSA) is associated with distinct morpho-functional and cardiometabolic features in elite athletes. Methods: We retrospectively included 2518 Olympic athletes. All underwent a pre-participation screening, including physical examination, ECG, blood analysis, echocardiography, and cardiopulmonary exercise testing. Participants were grouped by sex-specific BSA percentiles: Group A (<5th percentile), Group B (25th–75th), and Group C (>95th percentile). Functional, echocardiographic, and cardio-metabolic parameters were compared among groups. Results: In male athletes, Group C showed higher resting systolic blood pressure (123.8 ± 10.4 mmHg) than Group B (117.4 ± 9.6, p < 0.0001) and Group A (110.4 ± 13, p < 0.0001), and a higher prevalence of dyslipidemia (31.7% vs. 11.1% in Group B and 4% in Group A, p = 0.031). Despite greater LVEDD (59 ± 3 mm in Group C vs. 55 ± 2.9 in B and 51.1 ± 3.1 in A, p < 0.0001) and LV mass (p < 0.0001), functional performance was lower in Group C, with VO2 max/kg of 35.2 ± 13.2 mL/min/kg vs. 44 ± 7.1 in B, and 47.8 ± 7.3 in A (p < 0.0001). Similar trends were observed in females for morpho-functional parameters, though lipid profiles did not significantly differ among groups (p > 0.05). Conclusions: Anthropometric traits significantly influence the cardiovascular and metabolic phenotype of elite athletes. Our findings support the integration of anthropometric profiling into the routine cardiovascular assessment of athletes, especially those at the extremes of body size, to better interpret physiological adaptations and risk profiles.

## Full-text entities

- **Diseases:** dyslipidemia (MESH:D050171)
- **Chemicals:** lipid (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12550917/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12550917/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12550917/full.md

---
Source: https://tomesphere.com/paper/PMC12550917